Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 14:11:37 UTC |
---|
Update Date | 2021-09-26 23:08:58 UTC |
---|
HMDB ID | HMDB0254750 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Mirodenafil |
---|
Description | Mirodenafil belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. Mirodenafil belongs to the drug class PDE5 inhibitors, which includes avanafil, sildenafil, tadalafil, udenafil, and vardenafil, and is the first-line treatment for erectile dysfunction. Mirodenafil is a very strong basic compound (based on its pKa). Several clinical trials were conducted, but mirodenafil has not been approved for use in the United States by the U.S. Food and Drug Administration. Developed by SK Chemicals Life Science, mirodenafil is marketed in Korea under the trade name Mvix, offered both as tablets (50 mg and 100 mg) and as orally dissolving film (50 mg). This compound has been identified in human blood as reported by (PMID: 31557052 ). Mirodenafil is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Mirodenafil is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCCOC1=CC=C(C=C1C1=NC2=C(N(CC)C=C2CCC)C(=O)N1)S(=O)(=O)N1CCN(CCO)CC1 InChI=1S/C26H37N5O5S/c1-4-7-19-18-30(6-3)24-23(19)27-25(28-26(24)33)21-17-20(8-9-22(21)36-16-5-2)37(34,35)31-12-10-29(11-13-31)14-15-32/h8-9,17-18,32H,4-7,10-16H2,1-3H3,(H,27,28,33) |
---|
Synonyms | Value | Source |
---|
5-Ethyl-2-(5-(4-(2-hydroxyethyl)piperazine-1-sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4H-pyrrolo(3,2-D)pyrimidin-4-one | MeSH | 5-Ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulphonyl}-2-propoxyphenyl)-7-propyl-5H-pyrrolo[3,2-D]pyrimidin-4-ol | Generator |
|
---|
Chemical Formula | C26H37N5O5S |
---|
Average Molecular Weight | 531.67 |
---|
Monoisotopic Molecular Weight | 531.251540485 |
---|
IUPAC Name | 5-ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl)-7-propyl-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one |
---|
Traditional Name | mirodenafil |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCOC1=CC=C(C=C1C1=NC2=C(N(CC)C=C2CCC)C(=O)N1)S(=O)(=O)N1CCN(CCO)CC1 |
---|
InChI Identifier | InChI=1S/C26H37N5O5S/c1-4-7-19-18-30(6-3)24-23(19)27-25(28-26(24)33)21-17-20(8-9-22(21)36-16-5-2)37(34,35)31-12-10-29(11-13-31)14-15-32/h8-9,17-18,32H,4-7,10-16H2,1-3H3,(H,27,28,33) |
---|
InChI Key | MIJFNYMSCFYZNY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzenesulfonamides |
---|
Direct Parent | Benzenesulfonamides |
---|
Alternative Parents | |
---|
Substituents | - Benzenesulfonamide
- Benzenesulfonyl group
- Pyrrolopyrimidine
- Phenoxy compound
- Phenol ether
- Pyrimidone
- Alkyl aryl ether
- N-alkylpiperazine
- 1,4-diazinane
- Piperazine
- Pyrimidine
- Substituted pyrrole
- Organosulfonic acid amide
- Pyrrole
- Heteroaromatic compound
- Vinylogous amide
- Sulfonyl
- Organosulfonic acid or derivatives
- Organic sulfonic acid or derivatives
- Tertiary aliphatic amine
- 1,2-aminoalcohol
- Tertiary amine
- Alkanolamine
- Ether
- Azacycle
- Organoheterocyclic compound
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Alcohol
- Organic oxide
- Organopnictogen compound
- Amine
- Hydrocarbon derivative
- Organic nitrogen compound
- Primary alcohol
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Mirodenafil,2TMS,isomer #1 | CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C)N(CC)C=C2CCC | 4226.8 | Semi standard non polar | 33892256 | Mirodenafil,2TMS,isomer #1 | CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C)N(CC)C=C2CCC | 4396.0 | Standard non polar | 33892256 | Mirodenafil,2TMS,isomer #1 | CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C)N(CC)C=C2CCC | 5795.4 | Standard polar | 33892256 | Mirodenafil,2TBDMS,isomer #1 | CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C(C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C(C)(C)C)N(CC)C=C2CCC | 4569.3 | Semi standard non polar | 33892256 | Mirodenafil,2TBDMS,isomer #1 | CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C(C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C(C)(C)C)N(CC)C=C2CCC | 4886.2 | Standard non polar | 33892256 | Mirodenafil,2TBDMS,isomer #1 | CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C(C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C(C)(C)C)N(CC)C=C2CCC | 5689.0 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Mirodenafil GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mirodenafil GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mirodenafil GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mirodenafil GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 10V, Positive-QTOF | splash10-001i-0001290000-f040ff7380f091548dc6 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 20V, Positive-QTOF | splash10-03du-6604970000-ed75101661d9235e2d43 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 40V, Positive-QTOF | splash10-0006-9131010000-0fab5ad5c2bd1da1ee3d | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 10V, Negative-QTOF | splash10-001i-0000490000-6d268f705ddfd9d18c0a | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 20V, Negative-QTOF | splash10-0flc-0200940000-d75ac7ef48b621e44b8a | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 40V, Negative-QTOF | splash10-01ox-3905500000-4fa6ac016892f592417f | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 10V, Positive-QTOF | splash10-001i-0000090000-7ac7e3b89177e028d9fb | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 20V, Positive-QTOF | splash10-0006-0001920000-9d598fd8f254deeb4b6a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 40V, Positive-QTOF | splash10-03di-3401910000-27a6c817cf6f3627a9d8 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 10V, Negative-QTOF | splash10-001i-0000190000-a8579751e49d6b8ec628 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 20V, Negative-QTOF | splash10-0a4r-0000920000-50d4d0848628e4bebe79 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mirodenafil 40V, Negative-QTOF | splash10-08fr-0010900000-5c6f3ce4a1543ebbeeb5 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB11792 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Mirodenafil |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 12001014 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|